Results 101 to 110 of about 5,063 (199)
S GROVER, H SUBRAMANYA
openaire +3 more sources
The State of the Art in Chronic Prurigo Nodularis. [PDF]
Serra-Baldrich E +6 more
europepmc +1 more source
Novel intralesional nemolizumab for chronic scalp prurigo nodularis. [PDF]
Gaven E, Siddiqui S, Stout M.
europepmc +1 more source
Prurigo nodularis in vitiligo patches: An unusual observation
Karim Saleh, MD, PhD
doaj +1 more source
Clinical Trial Comparison of Dupilumab and Nemolizumab for Prurigo Nodularis FDA-Approved Biologic Therapy Selection in Prurigo Nodularis. [PDF]
Robertson A, Rohan C.
europepmc +1 more source
Prurigo nodularis patients face a significant burden of comorbidities, necessitating a comprehensive approach to care. We aimed to explore the association between prurigo nodularis, its comorbid conditions, and healthcare usage patterns.BACKGROUNDPrurigo
Czarnowicki, Tali +4 more
core +1 more source
Treatment of immunotherapy-associated pruritus and prurigo nodularis refractory to dupilumab with nemolizumab. [PDF]
Luo AJ +3 more
europepmc +1 more source
• Real-world data reveal that dupilumab therapy for prurigo nodularis is effective and well tolerated in the short term, but ophthalmic adverse events frequently occur. • Clinical trials demonstrated that dupilumab is effective and safe for the treatment
Titou, Hicham
core +1 more source

